A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of RC017 Ophthalmic Ointment Following Single and Multiple Doses in Healthy Adult Participants

NCT07521748 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: RC017 Ophthalmic Ointment
DRUG: RC017 Ophthalmic Ointment placebo

Sponsor

Nanjing Reju Therapeutics Co., Ltd